A Clinical Study of SPH7854 Granules in Healthy Subjects.

Inclusion criteria

• Volunteer to participate in clinical research; Fully understand and know the study and sign the informed consent；
• Healthy volunteers;
• Before receiving the investigational drug, the examination results were normal or clinically insignificant;
• Subjects who have no fertility plan/sperm donation/egg donation plan and voluntarily take effective contraceptive measures, from signing the informed consent to the prescribed time after the last dosing.

Exclusion criteria

• Female subjects who are breastfeeding or have positive pregnancy results;
• Subjects with chronic, unstable, or recurrent disease or surgery history who are judged by the investigator to be ineligible before signing informed consent;
• Subjects suffering from allergic diseases or having a history of severe allergies;
• Subjects who took the drug or food prohibited by the protocol prior to the first dose;
• Subjects with evidence of infection who could not be enrolled according to the investigator's judgement;
• Other circumstances that meet the protocol exclusion criteria.